Albendazole
265.33Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester.
Methyl 5-(propylthio)-2-benzimidazolecarbamate
[54965-21-8].» Albendazole contains not less than 98.0 percent and not more than 102.0 percent of C12H15N3O2S, calculated on the dried basis.
Packaging and storage—
Preserve in tight containers, and store at controlled room temperature.
Identification—
B:
The RF value of the principal spot observed in the chromatogram of the test solution corresponds to that of the principal spot observed in the chromatogram of the Standard solution, as obtained in the test for Chromatographic purity.
Loss on drying 
731
—
Dry it at 105
for 4 hours: it loses not more than 0.5% of its weight.
731—
Dry it at 105 for 4 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281:
not more than 0.2%.
281:
not more than 0.2%.
Chromatographic purity—
Dissolve 50 mg of it in 3.0 mL of glacial acetic acid in a 5-mL volumetric flask, dilute with glacial acetic acid to volume, and mix. Similarly prepare a Standard solution containing 5 mg of USP Albendazole RS per mL. Transfer 1.0 mL of the Standard solution to a 100-mL volumetric flask, dilute with glacial acetic acid to volume, and mix (diluted Standard solution). Apply 10-µL portions of the test solution, the Standard solution, and the diluted Standard solution to a suitable thin-layer chromatographic plate (see Chromatography 621), coated with a 0.25-mm layer of silica gel mixture, and allow the spots to dry. Develop the chromatogram in a solvent system consisting of a mixture of chloroform, glacial acetic acid, and ether (60:10:10) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, allow the solvent to evaporate from the plate, and examine the plate under short-wavelength UV light: no spot, other than the principal spot, in the chromatogram of the test solution is larger or more intense than the principal spot in the chromatogram of the diluted Standard solution (0.5%).
621), coated with a 0.25-mm layer of silica gel mixture, and allow the spots to dry. Develop the chromatogram in a solvent system consisting of a mixture of chloroform, glacial acetic acid, and ether (60:10:10) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, allow the solvent to evaporate from the plate, and examine the plate under short-wavelength UV light: no spot, other than the principal spot, in the chromatogram of the test solution is larger or more intense than the principal spot in the chromatogram of the diluted Standard solution (0.5%).
Change to read:
Assay—
Transfer about 250 mg of Albendazole, accurately weighed, to a suitable flask, and dissolve in 100 mL of glacial acetic acid, warming gently if necessary. Cool, 
USP32 and titrate with 0.1 N perchloric acid VS to a potentiometricUSP32 endpoint (see Titrimetry 541.USP32 Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 26.53 mg of C12H15N3O2S.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
| Monograph | Ian DeVeau, Ph.D.
Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178 |
(VET05) Veterinary Drugs 05 |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
USP32–NF27 Page 1435
Pharmacopeial Forum: Volume No. 34(1) Page 69